Mona S. Jhaveri-Brown
Corporate Officer/Principal bei National Cancer Institute
Profil
Mona S.
Jhaveri-Brown is Founder and Chief Executive Officer of Foligo Therapeutics, Inc. she is a Member of National Cancer Institute.
Dr. Jhaveri-Brown received a PhD in Biochemistry from Wake Forest University.
Aktive Positionen von Mona S. Jhaveri-Brown
| Unternehmen | Position | Beginn |
|---|---|---|
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 27.05.2009 |
Ehemalige bekannte Positionen von Mona S. Jhaveri-Brown
| Unternehmen | Position | Ende |
|---|---|---|
Foligo Therapeutics, Inc.
 Foligo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Foligo Therapeutics, Inc. developed cancer therapeutics. The company was founded by Mona S. Jhaveri-Brown in April 11, 2006 and headquartered in Baltimore, MD. | Vorstandsvorsitzender | - |
Ausbildung von Mona S. Jhaveri-Brown
| Wake Forest University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Foligo Therapeutics, Inc.
Foligo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Foligo Therapeutics, Inc. developed cancer therapeutics. The company was founded by Mona S. Jhaveri-Brown in April 11, 2006 and headquartered in Baltimore, MD. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
